Bison Capital Acquisition Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (7)

Latest Posts

About This Stock More About This Stock
Week In Review: Nanjing's NJCTTQ Agrees To $4 Billion Package For Abpro Bi-Specific Immunotherapies
Article By: ChinaBio® Today
Saturday, March 2, 2019 4:14 PM EDT
NJCTTQ, a Nanjing biopharma, announced a deal worth up to $4 billion to co-develop bispecific immunotherapies discovered by Abpro of Massachusetts.
In this article: ASLN, BCAC

Latest Tweets for $BCAC

No tweets yet!